NVIDIA just doubled its revenue per gigawatt of AI capacity and posted triple-digit earnings growth, yet its stock has struggled to keep pace with the profits. A $350 price target sounds ambitious until you…
Wall Street's analyst community has reached something close to a verdict on Amazon, and the bears are nowhere to be found. But the real question is whether AWS's $496 billion backlog and surging AI…
Bloom Energy shares have already surged over 200% this year, yet Wall Street's consensus target barely budges. A closer look at the numbers reveals why one specific price could still be achievable by 2027.
Marvell has already surged more than 200% this year, yet bulls are pushing price targets well past current levels as a major Investor Day announcement and a fresh analyst upgrade suggest the custom silicon…
Skyrizi and Rinvoq are growing fast, a blockbuster acquisition just closed, and the FDA handed AbbVie a fresh approval, yet the stock sits just shy of a price target that has Wall Street divided…
While the AI spotlight stays fixed on megacap darlings, one under-the-radar software company quietly sits at the center of every chip those giants design, and analysts are starting to notice the gap between its…
Broadcom management called Q3 demand simply hot, and Marvell and AMD have already tripled in 2026 alone. The question now is whether three bold price targets for 2027 are ambitious or just the beginning.
Goldman Sachs just broke from the Wall Street pack and handed Palantir a rare upgrade, arguing the AI data company is entering a new growth phase that could stretch well beyond what most analysts…
Intel shares have already surged more than 200% this year, but Wall Street still calls the stock a hold. Here is what bulls and skeptics are each missing about where INTC goes from here.
Nvidia stock has already handed investors gains most people only dream about, yet Wall Street analysts keep raising their targets and the company's newest chips are just hitting the market. Here is what needs…
Amazon just slammed the door on Meta's Muse agent, yet Wall Street is not flinching. Here is why one major bank sees the block as a footnote to a much bigger story unfolding inside…
Nvidia grabs the AI headlines, but every leading-edge chip it sells has to pass through one company's factories first, and that company trades at a fraction of its biggest customer's valuation.
A $10,000 stake in Broadcom a decade ago grew into a life-changing sum, but the company that delivered those gains barely resembles the one investors face today. Whether AI demand can fuel another historic…
Alphabet just posted one of its best quarters ever, yet the stock sits nearly 15% below its May peak while Wall Street quietly raises its targets. Three specific catalysts could push shares to a…
AWS just posted its fastest growth in 18 quarters, OpenAI and Anthropic locked in gigawatts of custom chip capacity, and yet Amazon shares sit 15% below their 52-week high. Something in that gap deserves…
Meta is spending more on AI than almost any company on earth, and that bet could either supercharge your monthly contributions or drag them down. Here is what four years of disciplined investing actually…
Nvidia sits at $5.70 trillion today, but a specific calendar date, a single earnings report, and one supply-constrained growth target could determine whether it crosses a threshold no company has ever reached.
Jensen Huang says NVIDIA could sell far more chips if only the supply existed, and that single constraint ripples through every memory and storage stock in the AI chain. Here is what it takes…
A $10,000 bet on AMD in 2011 grew into more than $1.2 million, but the AI boom that sent shares soaring 211% in a single year raises a harder question: how much runway is…
Cantor Fitzgerald just bumped price targets on Eli Lilly, AbbVie, Merck, and Pfizer, but higher targets do not mean equal conviction. The firm's split between Overweight and Neutral ratings reveals a sharp divide in…
